In patients with chronic atrial fibrillation and left ventricular systolic dysfunction, restoration of sinus rhythm confers substantial benefit

Chest

Volumn 120, Issue 1, 2001, Pages 132-138

  Azpitarte, J ^a   Baun O ^a   Moreno, E ^a   Garcia Orta R ^a   Sanchez Ramos J ^a   Tercedor, L ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Amiodarone; Atrial fibrillation; Case control study; Electrical countershock; Heart failure; Left ventricular dysfunction

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROSTIMULATION THERAPY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART RATE; HEART VENTRICLE CONTRACTION; HUMAN; MALE; PRIORITY JOURNAL; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 0034887223     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.1.132     Document Type: Article

References (41)

1. Incidence and etiology of heart failure: A population-based study
2. Auricular fibrillation with congestive heart failure and no other evidence of heart disease
3. Auricular fibrillation without other evidence of heart disease: A cause of reversible heart failure
4. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: Complete recovery after restoration of sinus rhythm
5. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy
6. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy
7. Left ventricular function in patients with atrial fibrillation before and after cardioversion
8. Heterogeneity and time course of improvement in cardiac function after cardioversion of chronic atrial fibrillation: Assessment of serial echocardio-graphic indices
9. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unasso-ciated with cardiac valve disease
10. Atrial and ventricular function after cardioversion of atrial fibrillation
11. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
12. Echocardio-graphic assessment of left ventricular hypertrophy: Comparison to necropsy findings
13. Significance of the atrial contribution to ventricular filling
14. Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle
15. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to SR
16. The effect of cardioversion on exercise capacity in patients with atrial fibrillation
17. Usefulness of low-dose dobutamine stress echocardiography in predicting recovery of poor left ventricular function in atrial fibrillation dilated cardiomyopathy
18. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies
19. Heart failure and atrial fibrillation: Current concepts and controversies
20. Left ventricular energetics in closed-chest dogs
21. Early recovery from heart failure: Insights into the pathogenesis of experimental chronic pacing-induced heart failure
22. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure
23. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction
24. What is meant by a "controlled" ventricular rate in atrial fibrillation?
25. Effect of irregular ventricular rhythm on cardiac output
26. Hemodynamic effects of irregular sequence of ventricular cycle lengths during atrial fibrillation
27. Autonomic modulation of ventricular rate in atrial fibrillation
28. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter
29. Improvement in left ventricular systolic function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation
30. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacologic treatment in patients with heart failure and chronic atrial fibrillation: A randomized, controlled study
31. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated by diuretics and vasodilators
32. Controlled trial of captopril in chronic heart failure: A rest and exercise hemodynamic study
33. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias: Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure
34. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
35. Long-term prognosis of patients with alcoholic cardiomyopathy and severe heart failure after total abstinence
36. Elevations of cardiac troponin I associated with myocarditis: Experimental and clinical correlates
37. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
38. Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation
39. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: A prospective study in 344 patients with baseline sinus rhythm
40. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular dysfunction: A retrospective analysis of the SOLVD trials
41. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations form the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT)